Revelation Biosciences Inc (FRA:56U0)
€ 8.88 0 (0%) Market Cap: 3.05 Mil Enterprise Value: 8.79 Mil PE Ratio: 0 PB Ratio: 0.32 GF Score: 24/100

Revelation Biosciences Inc Corporate Update Call Transcript

Jan 11, 2022 / 09:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Revelation Biosciences corporate update conference call. (Operator Instructions) With us today, we have CEO, James Rolke; CFO, of Chester Zygmont; and Vice President, Investor Relations and Human Resources, Sandra Vedrick. Ms. Vedrick, the floor is yours.

Sandra Vedrick
Revelation Biosciences, Inc. - VP, Human Resources and IR

Thank you, operator, and thank you, everyone, for taking time to learn about Revelation Biosciences today. I would like to remind everyone that today's call is being recorded and the replay will be available on our website.

This conference call and the presentation today contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 as amended. Forward-looking statements are statements that are not historical facts. These forward-looking statements are generally identified by the words anticipate, believe, expect, estimate, plan, outlook, and protect, and other risks similar expressions. We caution investors that forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot